Financial insights of SONM

MyFinsight

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total net revenues	NaN	NaN	16,214	11,190
Cost of revenues	NaN	NaN	14,398	10,345
Gross profit	NaN	NaN	1,816	845
Research and development	NaN	NaN	181	909
Sales and marketing	NaN	NaN	2,452	3,445
General and administrative	3,618	-3,819	3,163	3,223
Impairment of contract fulfillment assets	NaN	NaN	NaN	0
Total operating expenses	3,618	-15,678	5,796	7,577
Net gain from operations	-3,618	4,661	-3,980	-6,732
Interest expense, net	-131	-484	-522	-389
Loss on extinguishment of debt	NaN	-161	NaN	NaN
Loss on remeasurement of derivative liability	-227	NaN	NaN	NaN
Equity income from dna x llc	48	-562	-161	-215
Net gain from continuing operations before income taxes	-3,928	3,454	-4,663	-7,336
Net loss from continuing operations	-3,928	-1,989*	NaN	NaN
Income tax expense	NaN	NaN	90	139
Income from discontinued operations, net of tax	10,268	-6,898*	NaN	NaN
Net income	6,340	-8,887	-4,753	-7,475

Basic EPS	5.01	-12.297	-4.83	-0.79
Diluted EPS	5.01	-12.297	-4.83	-0.79
Basic Average Shares	1,265,067	722,689*	984,927	9,510,601
Diluted Average Shares	1,265,067	722,689*	984,927	9,510,601

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.